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Venous Thromboembolism – Risk Assessment Tool and
Thromboprophylaxis Policy: A National Survey
MI Khan, C O’Leary, V Silvari, A O’Brien, M O’Connor, C Duggan, S O’Shea
Cork University Hospital
Abstract
Venous Thromboembolic (VTE) events in hospitalised patients are associated with significant
mortality and morbidity and a major economic burden on the health service. It is well established
in the literature that active implementation of a mandatory risk assessment tool and
thromboprophylaxis policy reduces the incidence of hospital associated thrombosis (HAT). This
study examines the utilization of a VTE risk assessment tool and thromboprophylaxis (TP) policy
in Irish hospitals that manage acute admissions. A national survey was distributed to forty acute
hospitals throughout Ireland. The response rate was 78% (31/40). The results showed that only
26% (n=8/31) of acute hospitals in Ireland have a local implemented TP policy. Six (75%) of these
eight had a risk assessment tool in conjunction with the TP policy. All respondents who did not
report to have a TP policy and risk assessment tool agreed that they should implement VTE
prevention policy at their hospital. Based on the data from this survey and evidence from the
effectiveness of the VTE prevention programme
introduced in the United Kingdom, there is a need for a national risk assessment and
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thromboprophylaxis policy in Ireland. This change in practice would have the potential to prevent
or reduce the morbidity and mortality associated with hospital acquired thrombosis
Introduction
Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism
(PE), is a major cause of preventable morbidity and mortality in hospitalized patients . In 2004 there were
more than half a million deaths related to VTE across the European Union . Three quarters of these
deaths were associated with Hospital Acquired Thrombosis (HAT). There is a consistent association
between the rising incidence of VTE and increasing age. In Ireland, 33% of the hospitalised population is
above 65 years . Prevention is the key to reduce death and disability resulting from HAT . There is no
national VTE risk assessment (RA) tool or thromboprophylaxis (TP) policy in Ireland. The aim of this
survey was to examine how many acute hospitals in Ireland utilise a VTE risk assessment tool and TP
policy.
Methods
There is no validated survey in the literature to collect the data required therefore a survey was
constructed by the investigating research team. The team included haematologists with a special interest
in haemostasis and thrombosis. The survey contained ten questions which collected data relating to
thromboprophylaxis policy and practices around the country (table 1). The survey was distributed by email
to all Chief Executive Officers (CEOs)/General Managers (GMs) and Clinical Directors of acute hospitals
in Ireland via the Medical Director of Cork University Hospital in April 2015.  Maternity, paediatric and non-
acute hospitals such as community hospitals were excluded from this survey. A hard copy of the survey
was also sent with a stamp addressed return envelope for those who preferred to use this method. 
Responses were anonymised to increase the response rate and openness. Results were analysed using
Microsoft Excel.
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Results
Forty surveys were distributed to hospitals throughout Ireland. Thirteen surveys were completed online
and eighteen were completed by post. This resulted in a response rate of 78% (31/40). Questions one
and two were excluded from analysis for the following reasons. Question one was unanswered by all
respondents. There was a technical difficulty with question two which meant that respondents were not
able to make multiple selections of the departments within their hospital using the online survey.
Therefore, it was decided by the investigators to exclude this question. A TP policy was implemented in
26% (n=8/31) hospitals.
Questions four to seven were only relevant to those that had a TP policy in place and focused on the
policy content. Eight out of eight hospitals reported their policy is based on National Institute of health and
Clinical Excellence (NICE) guidelines. One respondent reported using American College of Chest
Physicians (ACCP) guidance in addition to NICE. Six (75%) of these eight had a risk assessment tool in
conjunction with the TP policy.
The sixth question addressed how users access this policy. Two thirds (n=6/8) reported their policy was
paper based and attached to the drug prescription chart and admission document. Two respondents
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reported the policy is accessible electronically.All respondents who had a TP policy (8/8) reported that
they regularly audit their TP policy.  All respondents who did not report to have a TP policy in their
hospital (n=23/31) agreed that a formal TP policy should be implemented. The ninth question addressed
the TP modalities used (Figure 1).
The last question in the survey asked respondents if they agreed or disagreed that “VTE, including DVT
and PE, is one of the most significant clinical problems in your hospital”. There was agreement among
42% (n=13/31) of responders and one respondent did not reply to this question.
Discussion
This is the first survey addressing the issue of thromboprophylaxis in Irish hospitals. It demonstrated wide
variations in practices among hospitals. VTE is a major cause of preventable morbidity and mortality in
hospitalized patients . Three quarters of Irish acute hospitals have no TP policy.  Hospital acquired
VTE may be prevented by risk assessing all hospitalised patients and prescribing thromboprophylaxis
where appropriate.
Following a report in 2007 from the Common Health Committee in the UK, that more than 25,000 deaths
in hospitals are related to VTE , a national VTE prevention programme was introduced in the United
Kingdom (UK). Implementation of the TP policy and risk assessment was mandatory in all National Health
Service (NHS) hospitals in England in 2010 . These hospitals were asked to meet the VTE risk
assessment screening target of 90% of hospitalised patients. To encourage compliance, these NHS
funded acute care providers were linked to the national Commissioning for Quality and Innovation
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(CQUIN) payment framework for 2010-2011 . This has shown a reduction in VTE related secondary
diagnosis, readmission and a reduction in VTE related mortality .
Based on the data from this survey and evidence from the VTE prevention programme introduced in the
United Kingdom, there is need for a national risk assessment and TP policy in Ireland. This would have
the potential to prevent or reduce the morbidity and mortality associated with hospital acquired
thrombosis. This study demonstrated willingness amongst hospitals, which did not already have a TP and
a risk assessment tool, to implement measures to prevent HAT.
Study limitations include the use of a non-validated questionnaire. Clinical directors/CEOs/GMs of acute
hospitals may not be aware of all local risk assessment tools and policies in their hospitals. The sampling
frame used limits the detection of individual clinicians’ practice patterns and there may be some
underestimation of the actual non documented TP practices within the hospital. Nevertheless, this survey
method yielded useful estimates of TP policies across Ireland with a good response rate.
The current lack of a national VTE risk assessment tool and TP policy within hospitals in Ireland is a
significant and acknowledged patient safety risk. Variability in clinical practice highlights the need for
rigorous efforts to develop and implement an evidence based national HAT prevention program.
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